286 related articles for article (PubMed ID: 31754397)
21. miR-485-5p suppresses Schwann cell proliferation and myelination by targeting cdc42 and Rac1.
Zhang Z; Li X; Li A; Wu G
Exp Cell Res; 2020 Mar; 388(1):111803. PubMed ID: 31877301
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-27a contributes to the malignant behavior of gastric cancer cells by directly targeting PH domain and leucine-rich repeat protein phosphatase 2.
Ding L; Zhang S; Xu M; Zhang R; Sui P; Yang Q
J Exp Clin Cancer Res; 2017 Mar; 36(1):45. PubMed ID: 28327189
[TBL] [Abstract][Full Text] [Related]
23. MiR-129-5p functions as a tumor suppressor in gastric cancer progression through targeting ADAM9.
Liu Q; Jiang J; Fu Y; Liu T; Yu Y; Zhang X
Biomed Pharmacother; 2018 Sep; 105():420-427. PubMed ID: 29879625
[TBL] [Abstract][Full Text] [Related]
24. POTEE promotes colorectal carcinoma progression via activating the Rac1/Cdc42 pathway.
Xu Q; Chen J; Peng M; Duan S; Hu Y; Guo D; Geng J; Zhou J
Exp Cell Res; 2020 May; 390(1):111933. PubMed ID: 32142855
[TBL] [Abstract][Full Text] [Related]
25. miR-133 is a key negative regulator of CDC42-PAK pathway in gastric cancer.
Cheng Z; Liu F; Wang G; Li Y; Zhang H; Li F
Cell Signal; 2014 Dec; 26(12):2667-73. PubMed ID: 25152372
[TBL] [Abstract][Full Text] [Related]
26. circLMTK2 acts as a sponge of miR-150-5p and promotes proliferation and metastasis in gastric cancer.
Wang S; Tang D; Wang W; Yang Y; Wu X; Wang L; Wang D
Mol Cancer; 2019 Nov; 18(1):162. PubMed ID: 31722712
[TBL] [Abstract][Full Text] [Related]
27. miR-509-3-5P inhibits the invasion and lymphatic metastasis by targeting PODXL and serves as a novel prognostic indicator for gastric cancer.
Zhang J; Zhu Z; Sheng J; Yu Z; Yao B; Huang K; Zhou L; Qiu Z; Huang C
Oncotarget; 2017 May; 8(21):34867-34883. PubMed ID: 28432273
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of geranylgeranyl diphosphate synthase contributes to tumour metastasis and correlates with poor prognosis of lung adenocarcinoma.
Wang X; Xu W; Zhan P; Xu T; Jin J; Miu Y; Zhou Z; Zhu Q; Wan B; Xi G; Ye L; Liu Y; Gao J; Li H; Lv T; Song Y
J Cell Mol Med; 2018 Apr; 22(4):2177-2189. PubMed ID: 29377583
[TBL] [Abstract][Full Text] [Related]
29. Rac1/Cdc42 and RhoA GTPases antagonistically regulate chondrocyte proliferation, hypertrophy, and apoptosis.
Wang G; Beier F
J Bone Miner Res; 2005 Jun; 20(6):1022-31. PubMed ID: 15883643
[TBL] [Abstract][Full Text] [Related]
30. GIT1 promotes lung cancer cell metastasis through modulating Rac1/Cdc42 activity and is associated with poor prognosis.
Chang JS; Su CY; Yu WH; Lee WJ; Liu YP; Lai TC; Jan YH; Yang YF; Shen CN; Shew JY; Lu J; Yang CJ; Huang MS; Lu PJ; Lin YF; Kuo ML; Hua KT; Hsiao M
Oncotarget; 2015 Nov; 6(34):36278-91. PubMed ID: 26462147
[TBL] [Abstract][Full Text] [Related]
31. MiR-361-5p inhibits colorectal and gastric cancer growth and metastasis by targeting staphylococcal nuclease domain containing-1.
Ma F; Song H; Guo B; Zhang Y; Zheng Y; Lin C; Wu Y; Guan G; Sha R; Zhou Q; Wang D; Zhou X; Li J; Qiu X
Oncotarget; 2015 Jul; 6(19):17404-16. PubMed ID: 25965817
[TBL] [Abstract][Full Text] [Related]
32. R-Ketorolac Targets Cdc42 and Rac1 and Alters Ovarian Cancer Cell Behaviors Critical for Invasion and Metastasis.
Guo Y; Kenney SR; Muller CY; Adams S; Rutledge T; Romero E; Murray-Krezan C; Prekeris R; Sklar LA; Hudson LG; Wandinger-Ness A
Mol Cancer Ther; 2015 Oct; 14(10):2215-27. PubMed ID: 26206334
[TBL] [Abstract][Full Text] [Related]
33. MiR-374b-5p suppresses RECK expression and promotes gastric cancer cell invasion and metastasis.
Xie J; Tan ZH; Tang X; Mo MS; Liu YP; Gan RL; Li Y; Zhang L; Li GQ
World J Gastroenterol; 2014 Dec; 20(46):17439-47. PubMed ID: 25516656
[TBL] [Abstract][Full Text] [Related]
34. Circular RNA circNRIP1 acts as a microRNA-149-5p sponge to promote gastric cancer progression via the AKT1/mTOR pathway.
Zhang X; Wang S; Wang H; Cao J; Huang X; Chen Z; Xu P; Sun G; Xu J; Lv J; Xu Z
Mol Cancer; 2019 Feb; 18(1):20. PubMed ID: 30717751
[TBL] [Abstract][Full Text] [Related]
35. CircRNA-104718 acts as competing endogenous RNA and promotes hepatocellular carcinoma progression through microRNA-218-5p/TXNDC5 signaling pathway.
Yu J; Yang M; Zhou B; Luo J; Zhang Z; Zhang W; Yan Z
Clin Sci (Lond); 2019 Jul; 133(13):1487-1503. PubMed ID: 31278132
[TBL] [Abstract][Full Text] [Related]
36. Downregulation of CYRI-B promotes migration, invasion and EMT by activating the Rac1-STAT3 pathway in gastric cancer.
Liu G; Xia Y; Wang H; Jin X; Chen S; Chen W; Zhang C; He Y
Exp Cell Res; 2023 Feb; 423(1):113453. PubMed ID: 36584745
[TBL] [Abstract][Full Text] [Related]
37. A Rac1/Cdc42 GTPase-specific small molecule inhibitor suppresses growth of primary human prostate cancer xenografts and prolongs survival in mice.
Zins K; Lucas T; Reichl P; Abraham D; Aharinejad S
PLoS One; 2013; 8(9):e74924. PubMed ID: 24040362
[TBL] [Abstract][Full Text] [Related]
38. miR-137 targets Cdc42 expression, induces cell cycle G1 arrest and inhibits invasion in colorectal cancer cells.
Liu M; Lang N; Qiu M; Xu F; Li Q; Tang Q; Chen J; Chen X; Zhang S; Liu Z; Zhou J; Zhu Y; Deng Y; Zheng Y; Bi F
Int J Cancer; 2011 Mar; 128(6):1269-79. PubMed ID: 20473940
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-195 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting the expression of VEGF, VAV2, and CDC42.
Wang R; Zhao N; Li S; Fang JH; Chen MX; Yang J; Jia WH; Yuan Y; Zhuang SM
Hepatology; 2013 Aug; 58(2):642-53. PubMed ID: 23468064
[TBL] [Abstract][Full Text] [Related]
40. Expression analysis of Cdc42 in lung cancer and modulation of its expression by curcumin in lung cancer cell lines.
Chen QY; Jiao DM; Yao QH; Yan J; Song J; Chen FY; Lu GH; Zhou JY
Int J Oncol; 2012 May; 40(5):1561-8. PubMed ID: 22266952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
